Votum World
Biotechnology firm specializing in the formulation, production, and distribution of organic and sustainable CBD products validated by clinical and veterinary studies.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor | €0.0 | round | |
* | N/A | €500k Valuation: €3.3m | Seed |
| Total Funding | 000k | ||
| EUR | 2022 | 2023 |
|---|---|---|
| Revenues | 0000 | 0000 |
| % growth | - | 135 % |
| EBITDA | 0000 | 0000 |
| Profit | 0000 | 0000 |
| % profit margin | 1 % | (9 %) |
| EV | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Company filings or news article
Votum World, a Spanish biotechnology company, was established with the goal of becoming a benchmark in the CBD market. The company is dedicated to the design, development, production, and distribution of organic and sustainable products containing cannabinoids.
The company's business model is centered around the direct-to-consumer sale of its products through its online CBD Shop and other marketplaces. Votum World offers a range of products for both humans and pets, including oils, creams, and supplements. A key aspect of their strategy is the in-house formulation of their products, which allows for greater control over quality and innovation. The company emphasizes the efficacy of its offerings, validating them through clinical and veterinary studies, a key differentiator in the crowded CBD market.
In a significant step for its growth, Votum World launched an investment round through the Startupxplore platform, successfully raising €432,000 to fuel its expansion and research and development efforts. The company serves the health and wellness market, providing alternatives that contribute to people's well-being.
Keywords: CBD, biotechnology, cannabinoids, wellness, e-commerce, pet care, supplements, skincare, clinical studies, sustainable products